Long-term follow-up of posterior capsule opacification after AquaLase and NeoSoniX phacoemulsification

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F16%3A10316843" target="_blank" >RIV/00179906:_____/16:10316843 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11150/16:10316843

Result on the web

<a href="http://dx.doi.org/10.5507/bp.2015.039" target="_blank" >http://dx.doi.org/10.5507/bp.2015.039</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5507/bp.2015.039" target="_blank" >10.5507/bp.2015.039</a>

Result language

angličtina

Original language name

Long-term follow-up of posterior capsule opacification after AquaLase and NeoSoniX phacoemulsification

Original language description

Aim. To compare the degree of posterior capsule opacification (PCO) after AquaLase and NeoSoniX phacoemulsification methods during an 8-year follow-up period using two types of software. Design. Prospective, randomized clinical trial. Methods. AquaLase was used in the right eye and NeoSoniX in the left eye of each patient with bilateral cataract. Results. Fifty patients were analyzed 1 year, 46 patients 3 years, and 37 patients 8 years after cataract surgery. Mean EPCO 2000 values were for the AquaLase group 0.324 +- 0.305 and for the NeoSoniX group 0.298 +- 0.341 (P = 0.53) 1 year after surgery, for the AquaLase group 0.582 +- 0.506 and for the NeoSoniX group 0.594 +- 0.515 (P = 0.87) 3 years after surgery, and for the AquaLase group 0.648 +- 0.567 and for the NeoSoniX group 0.673 +- 0.542 (P = 0.30) 8 years after surgery. The OSCA results were for the AquaLase group 0.7097 +- 0.3778 and for the NeoSoniX group 0.8584 +- 0.4323 (P = 0.046) 1 year after surgery, for the AquaLase group 0.9667 +- 0.736 and for the NeoSoniX group 0.9540 +- 0.5250 (P = 0.91) 3 years after surgery, and for the AquaLase group 1,035 +- 0,952 and for the NeoSoniX group 1,103 +- 0,741 (P = 0.44) 8 years after surgery. Conclusion. There was minimal PCO difference between these 2 approaches, AquaLase and NeoSoniX. Neither AquaLase nor NeoSoniX technique was able to prevent a natural progression of PCO.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FF - ENT (ie. ear, nose, throat), ophthalmology, dentistry

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2016

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Biomedical Papers

ISSN

1213-8118

e-ISSN

—

Volume of the periodical

160

Issue of the periodical within the volume

1

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

6

Pages from-to

143-148

UT code for WoS article

000373390800020

EID of the result in the Scopus database

2-s2.0-84962339948